<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: agency for healthcare research</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'agency for healthcare research'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22agency+for+healthcare+research%22&t=%22agency+for+healthcare+research%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:34:14 +0100</lastBuildDate>
        <item>
            <title>Whither Comparative Effectiveness Research?</title>
            <link>http://www.medworm.com/index.php?rid=4780485&amp;cid=t_228736_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FU_8pduWA8bk%2F</link>
            <description>How soon might comparative effectiveness offer significant change? And which entities will guide these changes when they begin? Inside the nation&amp;#8217;s capitol, CER has become something of a mantra among those hoping to drive down health care costs. But beyond the Beltway, CER appears not to be nearly as potent a concept, for now anyway.
To gauge the extent to which CER is perceived, the National Pharmaceutical Council, a policy and research organization supported by pharma, surveyed 111 people from federal agencies, consumer and trade groups, insurers and academics, among others. And NPC found nearly 60 percent are &amp;#8220;very familiar” with CER, but only 30 percent believe CER will lead to moderate improvements in health care decision-making in the next year. 
One reason for the lack...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4780485</comments>
            <pubDate>Tue, 03 May 2011 13:36:25 +0100</pubDate>
            <guid isPermaLink="false">4780485</guid>        </item>
        <item>
            <title>Conference on Preventing Medical Errors in Mumbai - 24 April 2011</title>
            <link>http://www.medworm.com/index.php?rid=4734248&amp;cid=t_228736_112_f&amp;fid=34971&amp;url=http%3A%2F%2Fblog.drmalpani.com%2F2011%2F04%2Fconference-on-preventing-medical-errors.html</link>
            <description>Medical errors are a leading cause of preventable deaths. When a patient dies because of perceived medical negligence, hospitals get burnt down and doctors get beaten up. However, not all deaths are because of negligence - and not all errors can be prevented. In order to learn about what we can do to make sure that medical errors are minimised , India's first Patient Safety Workshop is being organised in Mumbai. This is the first conference in India which focuses on this key issue, which is usually misunderstood; and often ignored.I am especially excited about the fact that this workshop will be involving patients as well, as I deeply believe that well-informed patients can play a very important role in preventing medical errors !We've got some great speakers - please do come and join us !...</description>
            <author>The Patient's Doctor</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4734248</comments>
            <pubDate>Sun, 17 Apr 2011 08:55:00 +0100</pubDate>
            <guid isPermaLink="false">4734248</guid>        </item>
        <item>
            <title>Conference on Preventing Medical Errors in Mumbai - 23 April 2011</title>
            <link>http://www.medworm.com/index.php?rid=4723981&amp;cid=t_228736_112_f&amp;fid=34971&amp;url=http%3A%2F%2Fblog.drmalpani.com%2F2011%2F04%2Fconference-on-preventing-medical-errors.html</link>
            <description>Medical errors are a leading cause of preventable deaths. When a patient dies because of perceived medical negligence, hospitals get burnt down and doctors get beaten up. However, not all deaths are because of negligence - and not all errors can be prevented. In order to learn about what we can do to make sure that medical errors are minimised , India's first Patient Safety Workshop is being organised in Mumbai. This is the first conference in India which focuses on this key issue, which is usually misunderstood; and often ignored.I am especially excited about the fact that this workshop will be involving patients as well, as I deeply believe that well-informed patients can play a very important role in preventing medical errors !We've got some great speakers - please do come and join us !...</description>
            <author>The Patient's Doctor</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4723981</comments>
            <pubDate>Sun, 17 Apr 2011 08:55:00 +0100</pubDate>
            <guid isPermaLink="false">4723981</guid>        </item>
        <item>
            <title>AHRQ: Healthcare Access And Racial Disparities Not Improving</title>
            <link>http://www.medworm.com/index.php?rid=4653331&amp;cid=t_228736_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fahrq-healthcare-access-and-racial-disparities-not-improving%2F2011.03.29</link>
            <description>According to American Medical News, the U.S. health system is demonstrating better performance on most measures of health care quality, but it’s failing to improve access to care or cut racial and ethnic health disparities, according to two reports released in February by the Agency for Healthcare Research and Quality.  “Quality of care continues to improve, but at a slow rate,” said Ernest Moy, MD, leader of the team at AHRQ that produced the reports.  ”In contrast to that, focusing on issues of access to care, not much has changed.  Focusing on disparities in care, not much changed…Those are bigger problem areas than overall quality of care.”  Measures related to hospital quality are showing the most improvement.  For example, in 2005, just 42% of patients with heart att...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4653331</comments>
            <pubDate>Tue, 29 Mar 2011 20:00:25 +0100</pubDate>
            <guid isPermaLink="false">4653331</guid>        </item>
        <item>
            <title>Women’s Health Update from AHRQ</title>
            <link>http://www.medworm.com/index.php?rid=4642588&amp;cid=t_228736_87_f&amp;fid=38368&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FDisruptiveWomenInHealthCare%2F%7E3%2FeM2gzPgZi_c%2F</link>
            <description>Women experience differences in their health care services and outcomes. The fact sheet, Healthcare Quality and Disparities in Women: Selected Findings, summarizes key findings from the National Healthcare Quality and Disparities Reports related to health care for women.



Related posts:Update From Haiti: Despair Sets In And Women Consider Suicide
The Society for Women’s Health Research: A Case Study of Advocacy for Women
Disruptive Women on the Radio&amp;#8230;with Real Women on Health (Source: Disruptive Women in Health Care)</description>
            <author>Disruptive Women in Health Care</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4642588</comments>
            <pubDate>Mon, 28 Mar 2011 13:42:36 +0100</pubDate>
            <guid isPermaLink="false">4642588</guid>        </item>
        <item>
            <title>Top 5 Most Expensive Classes Of Prescription Drugs</title>
            <link>http://www.medworm.com/index.php?rid=4527735&amp;cid=t_228736_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Ftop-5-most-expensive-classes-of-prescription-drugs%2F2011.02.27</link>
            <description>The top five therapeutic classes ranked by total expense are metabolic, central nervous system, cardiovascular, gastrointestinal, and psychotherapeutic, altogether totaling $155.7 billion, or two-thirds of prescription drug expenses by U.S. adults in 2008.
Two-thirds of American adults use a prescription drug, totaling the $232.6 billion in expenses. The Agency for Healthcare Research and Quality compiled a statistical brief showing that drug classes varied widely in how they made the top five list. While 46 percent of adults with a prescribed drug expense bought a central nervous system agent, they are relatively cheaper on average. Gastrointestinal agents had the highest average expense per prescription ($133), or more than three times the average expense of the cheapest class, which wa...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4527735</comments>
            <pubDate>Sun, 27 Feb 2011 15:00:00 +0100</pubDate>
            <guid isPermaLink="false">4527735</guid>        </item>
        <item>
            <title>The Cost Of Treating Kidney Disease</title>
            <link>http://www.medworm.com/index.php?rid=4482759&amp;cid=t_228736_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fthe-cost-of-treating-kidney-disease%2F2011.02.15</link>
            <description>Medical spending to treat kidney disease totaled on average $25.3 billion annually from 2003 to 2007 (in 2007 dollars). Almost half of the expenditures ($12.7 billion) were spent on ambulatory visits.
On average, 3.7 million adults (1.7 percent of the population) annually reported getting treatment for kidney disease, reports a statistical brief from the Agency for Healthcare Research and Quality. During 2003-2007, for those ages 18 to 64, more than half of the total kidney disease expenditures were from ambulatory visits (53.1 percent) compared with about one third (30.3 percent) from inpatient visits. Among those age 65 and older, ambulatory visits accounted for 46 percent of the total kidney disease expenditures and hospital stays were 43 percent.
Similar amounts were spent on prescri...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4482759</comments>
            <pubDate>Tue, 15 Feb 2011 18:00:00 +0100</pubDate>
            <guid isPermaLink="false">4482759</guid>        </item>
        <item>
            <title>AMIA: Why The “Hold Harmless” Clause In EMR Contracts Is Unethical</title>
            <link>http://www.medworm.com/index.php?rid=4172061&amp;cid=t_228736_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Famia-board-%25e2%2580%259chold-harmless%25e2%2580%259d-clause-in-emr-contracts-is-unethical%2F2010.11.16</link>
            <description>Last Friday the board of the American Medical Informatics Association (AMIA) published a position paper in its journal saying that the “hold harmless” clause is unethical. One of the paper’s authors is Dr. Danny Sands, currently President of the Society for Participatory Medicine. I hope to write more about it this week, after attending the AMIA conference in DC, but here’s the basic issue:
&amp;#8211; For ages, makers of electronic medical record systems (EMR) have insisted on a “hold harmless” clause in the contracts a system buyer must sign. It says, in essence, that if any harm comes to anyone because of a system problem, the buyer (the hospital) will hold the manufacturer harmless.
&amp;#8211; In other words, if anything goes wrong with the system and someone gets hurt, it’s not...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4172061</comments>
            <pubDate>Tue, 16 Nov 2010 15:00:17 +0100</pubDate>
            <guid isPermaLink="false">4172061</guid>        </item>
        <item>
            <title>What A ‘68 Chevy Impala Can Tell Us About Primary Care</title>
            <link>http://www.medworm.com/index.php?rid=3822920&amp;cid=t_228736_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fwhat-a-68-chevy-impala-can-tell-us-about-primary-care%2F2010.08.04</link>
            <description>When I was a much younger man I had a 1968 Chevy Impala. I loved its V-8 engine and spaciousness, but I paid a steep price for it. It consumed gas like a drunk on a binge. It was prone to breakdowns, usually in the left lane of a busy highway. Even as it consumed my limited financial resources, I couldn&amp;#8217;t count on it to reliably get me to where I wanted to be. Yet I held onto it. One day, though, its transmission gave out, and I finally had to resign myself to buying a new, more reliable, more modern, and efficient vehicle. Yet to this day, I miss my clunker.
I am reminded of this when I think about the state of primary care today. Many of us are attached to a traditional primary care model that may no longer be economically viable &amp;#8212; for physicians, for patients, and for purcha...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3822920</comments>
            <pubDate>Wed, 04 Aug 2010 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">3822920</guid>        </item>
        <item>
            <title>For Adults, Drug Costs Doubled From ‘96 to ‘06</title>
            <link>http://www.medworm.com/index.php?rid=3075765&amp;cid=t_228736_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Frr47beVX4Cs%2F</link>
            <description>The average cost for an American between 18 and 44 years of age was double the inflation-adjusted average for 1996, according to recently released data from the Agency for Healthcare Research and Quality, or AHRQ. To be precise, the cost went from $79 to $161.
Prescription meds also accounted for what AHRA calls a &amp;#8220;notably larger share of all health care expenses&amp;#8221; for this age group in 2006 - it was 18 percent compared with 10 percent in 1996. This occurred even though the proportion who purchased prescription drugs dropped over the same period from 60 percent to 54 percent.
For Americans age 18 to 44, health care expenses totaled $231 billion in 2006 or about $40 billion more than in 1996 after accounting for inflation; a smaller proportion incurred health care expenses in 200...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3075765</comments>
            <pubDate>Thu, 10 Dec 2009 11:37:48 +0100</pubDate>
            <guid isPermaLink="false">3075765</guid>        </item>
        <item>
            <title>Medication Adherence Requires a Team-based Approach</title>
            <link>http://www.medworm.com/index.php?rid=2950732&amp;cid=t_228736_87_f&amp;fid=38368&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FDisruptiveWomenInHealthCare%2F%7E3%2F6M5n_DTj85w%2F</link>
            <description>As our population ages the importance of one’s ability to remain independent as long as possible will become even more important than it is today. One of the leading causes for the placement of a frail adult in a nursing home is due to non-adherence to medication regimes. In fact, 10 to 25 percent of hospital and nursing home admissions annually are because of an individual’s lack of adherence.
The American Academy of Nursing working with the Agency for Healthcare Research and Quality has published practice guidelines for nurses working with the older adults in the community on the management of their medication. There are many risk factors that affect the individual’s adherence from physical ability to depression and beyond.
We know that nursing interventions and evidenced based tra...</description>
            <author>Disruptive Women in Health Care</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2950732</comments>
            <pubDate>Mon, 02 Nov 2009 13:03:11 +0100</pubDate>
            <guid isPermaLink="false">2950732</guid>        </item>
        <item>
            <title>National Consumers League – National Medication Adherence Campaign</title>
            <link>http://www.medworm.com/index.php?rid=2912187&amp;cid=t_228736_87_f&amp;fid=38368&amp;url=http%3A%2F%2Fwww.talkaboutrx.org%2Fdocuments%2Fenhancing_prescription_medicine_adherence.pdf</link>
            <description>As Robin illustrated in her post, poor medication adherence results in poor health outcomes for millions of Americans, and costs billions of dollars in increased medical costs.  When three-quarters of Americans concede they don’t take their prescription medications as directed, we are faced with a public health problem that demands a broad, multi-faceted response.
As the nation’s oldest consumer organization, the National Consumers League has long worked to improve medication safety, patient education, and consumer education in the health community.  With planning funds from the Agency for Healthcare Research and Quality (AHRQ), NCL is spearheading a first-of-its-kind national education campaign to raise consumer awareness of the importance of good medication adherence.  As called f...</description>
            <author>Disruptive Women in Health Care</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2912187</comments>
            <pubDate>Wed, 21 Oct 2009 11:18:55 +0100</pubDate>
            <guid isPermaLink="false">2912187</guid>        </item>
        <item>
            <title>Grey Literature: Time to make it systematic</title>
            <link>http://www.medworm.com/index.php?rid=2772495&amp;cid=t_228736_86_f&amp;fid=38272&amp;url=http%3A%2F%2Flaikaspoetnik.wordpress.com%2F2009%2F09%2F06%2Fgrey-literature-time-to-make-it-systematic%2F</link>
            <description>Guest author: Shamsha Damani (@shamsha)
Grey literature is a term I first encountered in library school; I remember dubbing it “the-wild-goose-chase search” because it is time consuming, totally un-systematic, and a huge pain altogether. Things haven’t changed much in the grey literature arena, as I found out last week, when my boss asked me to help [...] (Source: Laika's MedLibLog)</description>
            <author>Laika's MedLibLog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2772495</comments>
            <pubDate>Sun, 06 Sep 2009 19:20:13 +0100</pubDate>
            <guid isPermaLink="false">2772495</guid>        </item>
        <item>
            <title>New checklists for staying healthy over 50</title>
            <link>http://www.medworm.com/index.php?rid=1709802&amp;cid=t_228736_117_f&amp;fid=36026&amp;url=http%3A%2F%2Fblog.healthtalk.com%2Fzimney%2Fnew-checklists-for-staying-healthy-over-50%2F</link>
            <description>Two new checklists designed to help people over the age of 50 learn what they can do to stay healthy have been released by the U.S. Agency for Healthcare Research and Quality (AHRQ) and the AARP. They provide all the information that women and men over 50 need to monitor and maintain their health. The two checklists are reprinted below, but originals can be obtained from the AHQR Web site, under the headings Tools and Resources, Health Care Consumers.


Women: Stay Healthy  at 50+ 


Checklists for Your Health
Use the checklists  in this flyer to help you stay healthy at 50+. The checklists help answer  your questions about what daily steps you can take for good health, whether  you need medicines to prevent disease, and which screening tests you need and  when to get them.Select to downlo...</description>
            <author>Dr. Z's Medical Report</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1709802</comments>
            <pubDate>Thu, 14 Aug 2008 23:57:11 +0100</pubDate>
            <guid isPermaLink="false">1709802</guid>        </item>
        <item>
            <title>Antidepressant Prescriptions Rose In 2005</title>
            <link>http://www.medworm.com/index.php?rid=1652557&amp;cid=t_228736_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F344662743%2F</link>
            <description>The increase amounted to roughly 10 percent, and that occurred in a year in which new and controversial Black Box warnings were added to the labeling on the medications. The data was just released by the Agency for Healthcare Research and Quality, a unit of the US Health and Human Services Department.
Those warnings sparked a debate over whether some doctors and patients were being scared away from useful drugs and, therefore, causing an increase in suicides. This contention then prompted an FDA official to say the warnings may have to be revisited if federal data yields such an increase, although the Centers for Disease Control &amp;#038; Prevention has yet to issue more recent numbers. (Back story).
The AHRQ found that, in 2002, there were 154.1 million antidepressant prescription purchases ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1652557</comments>
            <pubDate>Thu, 24 Jul 2008 14:40:45 +0100</pubDate>
            <guid isPermaLink="false">1652557</guid>        </item>
        <item>
            <title>The Cholesterol Craze: Statin Use Skyrocketed</title>
            <link>http://www.medworm.com/index.php?rid=1543927&amp;cid=t_228736_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F319928034%2F</link>
            <description>Most likely, you will not find this surprising. In any event, the use of cholesterol-lowering pills - otherwise known as statins - rose by 156 percent between 2000 and 2005, according to the US Agency for Healthcare Research and Quality. The number of people obtaining a prescription for a statin nearly doubled, from 15.8 milllion to 29.7 million. Looked at another way, the number of outpatient scrips rose to nearly 174 million from about 90 million. 
Along with the usage, the register rang innumerable times - spending jumped during that period to $19.7 billion from $7.7 billion. Each individual spent $484 a year, on average, to lower their cholesterol in 2000, and that rose to $661 by 2005. Although the AHRQ report doesn&amp;#8217;t look at the past three years, the individual spending may hav...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1543927</comments>
            <pubDate>Wed, 25 Jun 2008 19:13:13 +0100</pubDate>
            <guid isPermaLink="false">1543927</guid>        </item>
        <item>
            <title>FDA, AHRQ To Study Heart Risk Of ADHD Pills</title>
            <link>http://www.medworm.com/index.php?rid=876182&amp;cid=t_228736_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F157638103%2F</link>
            <description>The agencies will collaborate in what they&amp;#8217;re calling &amp;#8216;the most comprehensive study to date&amp;#8217; of the potential for increased risk of heart attack, stroke or other cardiovascular problems associated with the widely used ADHD meds. 
Researchers supported by the Agency for Healthcare Research and Quality and the FDA will examine the clinical data of about 500,000 children and adults. The move comes after the FDA last February issued warnings about cardiovascular and psychiatric side effects associated with Adderall, Strattera, Ritalin and Concerta, among others. 
ADHD meds can increase heart rate and blood pressure, prompting concerns increased cardiac risks. Moreover, the risks may be different for adults and children, but more evidence is needed about the long-term effects,...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=876182</comments>
            <pubDate>Mon, 17 Sep 2007 15:18:27 +0100</pubDate>
            <guid isPermaLink="false">876182</guid>        </item>
    </channel>
</rss>

